Recent Finacing
Recent Raise
Syantra's Syantra DX breast cancer test measures whole-blood gene-expression panels and uses machine-learning software, operating under ISO 13485 and CLIA/COLA/CPSA with CE‑IVD and UKCA markings.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Syantra.
